IDO1 and lung carcinoma: In a lung cancer study, it was found that the impaired differentiation and function of DCs was due to tryptophan degradation, which was caused by both CAF-released IDO1 and lung-cancer-derived galectin-1-induced tryptophan 2,3-dioxygenase (TDO2) [119].